CAR T-cell therapy holds promise for multiple myeloma – Healio
|
CAR T-cell therapy holds promise for multiple myeloma
Healio NEW YORK — Cellular immunotherapies such as chimeric antigen receptor therapy are a promising approach for treatment of multiple myeloma, according to a presenter at HemOnc Today New York. CAR T cells have impressive activity against leukemia and … |
